Drug regulators flag failures in quality management system; Sun Pharmaceutical’s compliance report under review. Indian drug regulators have directed Sun Pharmaceutical Industries, the country's largest pharmaceutical company, to stop manufacturing, selling and distributing ophthalmic products produced at its Assam facility after identifying significant deficiencies in its quality management system.